美国广播公司新闻：莫兰巴男子因袭击拒绝新冠疫苗豁免的全科医生而被指控
继我们最近关于 COVID-19 强制疫苗接种、无过错赔偿和医疗豁免的 CVU 小组讨论之后，本文重点介绍了医护人员因社区中一些成员对强制疫苗接种感到威胁和恐惧而遭受的虐待。
要阅读全文，请点击以下链接：
美国广播公司新闻：莫兰巴男子因袭击拒绝新冠疫苗豁免的全科医生而被指控
要了解有关维多利亚州 COVID-19 强制疫苗接种说明的更多信息，请点击以下链接：
MVEC：维多利亚州 COVID-19 强制疫苗接种指南
CBS News: Flu outbreak hits University of Michigan as some students prepare to travel for Thanksgiving holiday: "There's vaccine fatigue"
The Centers for Disease Control and Prevention (CDC) are investigating approximately 530 reported cases of influenza at the University of Michigan, with 77% of them being unvaccinated against influenza. In addition to this, health officials have also reported an increase of viruses like RSV and influenza, which Michigan hasn't seen in more than a year, as well as a surge in COVID-19 cases among those who are unvaccinated.
New resource developed by NCIRS: Decision Aid: Should I get the COVID-19 vaccine?
The National Centre for Immunisation Research and Surveillance (NCIRS) have developed a simple resource to help individuals in making the decision on whether COVID-19 vaccination is right for them.
The resource was created by leading experts in immunisation and Public Health and has been designed in 5 simple steps to provide information on the COVID-19 virus and vaccines, weigh up the risks and benefits of vaccination, and assist in making a decision.
To access the Decision Aid, please click on the link below:
New resource developed by NCIRS: Decision Aid: Should I get the COVID-19 vaccine?
The Conversation: No, vaccinated people are not ‘just as infectious’ as unvaccinated people if they get COVID
Recent studies have shown similar peak viral loads in vaccinated people who contract COVID-19 disease compared with unvaccinated people who contract COVID, raising questions around the impact that vaccination has on preventing transmission.
This article discusses the findings from recent studies on viral load and further explores the impact that vaccination has on those who experience breakthrough disease. It specifically highlights how vaccinated individuals with breakthrough disease can clear the virus faster, have lower levels of the virus overall, and therefore are less contagious.
要阅读全文，请点击以下链接：
The Conversation: No, vaccinated people are not ‘just as infectious’ as unvaccinated people if they get COVID
New Kids Health Info Podcast Episode - Fear of needles. What helps?
A new episode of the popular Kids Health Info podcast on the Fear of needles is now available.
In this session, the hosts are joined by two special guests - Sonja Elia, an Immunisation Nurse Practitioner and head of the RCH Immunisation Drop-In Centre, and Dr Amanda Stock, a Paediatrician and Emergency Physician from the RCH where they discuss helpful strategies and techniques available to children and families to manage anxiety about needles.
To listen to the podcast, please click on the link below:
Kids Health Info podcast: Fear of needs. What helps?
Healthed Going Viral Podcast featuring A/Prof Nigel Crawford
MVEC’s Associate Professor Nigel Crawford delivered the COVID-19 Update as part of the recent Healthed Australia online lecture series.
In this lecture, A/Prof Nigel Crawford discussed the following:
- COVID booster dose
- Myocarditis following mRNA vaccine
- Vaccinating 5-11-year-olds with Pfizer
- Best vaccine delivery method
- Opening the borders – don’t forget there are many vaccine-preventable diseases (VPDs)
To listen to the lecture in full, click on the link below:
Healthed lecture series 11 November: COVID-19 Update
The Conversation: Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccination
The COVID-19 pandemic has perpetuated rapid medical advancements and technological innovations. Over the last 20 months, we’ve experienced an influx of new vaccines which have proven to be safe and effective in preventing disease.
Scientists and researchers around the world are already working on the next generation of COVID vaccines to help tackle issues regarding waning immunity, storage and delivery, and vaccine hesitancy. Focusing their efforts on making vaccination easier, delivering more durable immunity and protecting against future variants
This article looks at the different considerations for research and technology around the world that will in turn lead to the next generation of COVID vaccines.
Follow the link to read the full article: Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccination
Moderna's COVID-19 vaccine (SPIKEVAX) - provisional determination granted for proposed use in children and booster shot for adults under evaluation
The Therapeutic Goods Administration (TGA) has granted provisional determination to Moderna Australia Pty Ltd in relation to its COVID-19 vaccine, SPIKEVAX.
SPIKEVAX is provisionally approved for use in individuals 12 years of age or older. The granting of this determination means that Moderna Australia Pty Ltd is eligible to apply to vary the provisional approval for the vaccine for use in younger children.
要阅读更多信息，请点击以下链接：
Moderna's COVID-19 vaccine (SPIKEVAX) - provisional determination granted for proposed use in children and booster shot for adults under evaluation
The Conversation: COVID vaccines for 5 to 11 year old’s are inching closer. Here’s what we know so far
This week, the US Food and Drug Administration (FDA) has authorised the provisional use of the Pfizer COVID-19 vaccine in children between the age of 5 to 11 years. Children will receive two doses of the vaccine, at a reduced dose (one-third of the adult dose) administered approximately three weeks apart.
Pfizer has submitted a partial application to Australia’s Therapeutic Goods Administration (TGA) and is currently on track to supply the remaining data over the next two weeks. Once approved, the Australian Technical Advisory Group on Immunisations (ATAGI) will advise the government on timing the rollout.
Current data suggests a clear advantage to immunising children against COVID-19, including protecting them from severe complications associated with the Delta variant, and helping to minimise the spread of the virus amongst the more vulnerable in the community.
Follow this link to read the full article:
COVID vaccines for 5 to 11 year old’s are inching closer. Here’s what we know so far
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
Novavax has completed the rolling regulatory submission to the U.K Medicines and Healthcare products Regulatory Agency (MHRA) for authorization of the first protein-based COVID-19 vaccine.
The NVX-CoV2373 vaccine is engineered from the genetic sequence of the first strain of SARS-CoV-2. Using Novavax recombinant nanoparticle technology to generate antigen derived from the coronavirus spike protein and is formulated with Novavax patented saponin-based Matrix-M ™ adjuvant to stimulate high levels of neutralizing antibodies.
Clinical data from Phase 3 trials included over 15,000 participants and demonstrated that NVX-CoV2373 elicited a strong immune response with an overall efficacy of 89.7% as well as a favourable safety and tolerability profile.
请点击以下链接阅读全文：
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom